Related Experiment Videos
Interferon beta-1a decreased the risk for conversion to clinically definite multiple sclerosis
1Dalhousie MS Research Unit, Halifax, Nova Scotia, Canada.
ACP Journal Club
|February 7, 2002
Summary
No abstract available in PubMed .